Yurai Okaji
- Molecular Biology top 10%
- Oncology top 10%
- Epidemiology top 10%
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Nelson H. TsunoHirokazu NagawaKoki TakahashiKazushige KawaiJoji KitayamaMasahiro AsakageYasutaka ShunoEiji Sunami
- Topics
- Angiogenesis and VEGF in Cancer (12 papers)Cell Adhesion Molecules Research (7 papers)Inflammatory mediators and NSAID effects (6 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Yurai Okaji
39 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 910
- Oncology 314
- Epidemiology 286
- Immunology 248
- Cancer Research 243
Countries citing papers authored by Yurai Okaji
This map shows the geographic impact of Yurai Okaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yurai Okaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yurai Okaji more than expected).
Fields of papers citing papers by Yurai Okaji
This network shows the impact of papers produced by Yurai Okaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yurai Okaji. The network helps show where Yurai Okaji may publish in the future.
Co-authorship network of co-authors of Yurai Okaji
This figure shows the co-authorship network connecting the top 25 collaborators of Yurai Okaji. A scholar is included among the top collaborators of Yurai Okaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yurai Okaji. Yurai Okaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 22 | |
| 3 | 47 | |
| 4 | 10 | |
| 5 | 69 | |
| 6 | 52 | |
| 7 | 18 | |
| 8 | 33 | |
| 9 | 56 | |
| 10 | Zoledronic acid inhibits gastric cancer cells by induction of apoptosis | 2 |
| 11 | 6 | |
| 12 | 37 | |
| 13 | 55 | |
| 14 | 7 | |
| 15 | 50 | |
| 16 | 22 | |
| 17 | 15 | |
| 18 | 17 | |
| 19 | 8 | |
| 20 | 33 |
About Yurai Okaji
Yurai Okaji is a scholar working on Applied Microbiology and Biotechnology, Immunology and Allergy and Immunology, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (12 papers), Cell Adhesion Molecules Research (7 papers) and Inflammatory mediators and NSAID effects (6 papers). The work is most often cited by research in Cancer Research (243 citations), Physiology (66 citations) and Biochemistry (85 citations). Yurai Okaji has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Nelson H. Tsuno, Hirokazu Nagawa, Koki Takahashi, Kazushige Kawai, Joji Kitayama, Masahiro Asakage, Joji Kitayama, Yasutaka Shuno, Eiji Sunami and Toshiaki Watanabe. Their work appears in journals such as Blood, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.